Rufinamide
Rank #441 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$18.0M
Total Cost
8,793
Total Claims
$18.0M
Total Cost
464
Prescribers
$2,044
Cost per Claim
23
Beneficiaries
9,381
30-Day Fills
$39K
Avg Cost/Provider
19
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$18.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $18.0M total
🔎 Data Overview
At $2,044 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $781,357 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Rufinamide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | David Labiner | Neurology | Tucson, AZ | 90 | $329K |
| 2 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 134 | $266K |
| 3 | Myriam Abdennadher | Neurology | Boston, MA | 44 | $261K |
| 4 | David Friedman | Neurology | Mineola, NY | 41 | $244K |
| 5 | Kimberly Konieczki | Nurse Practitioner | Erie, PA | 35 | $210K |
| 6 | Deborah Zielinski | Nurse Practitioner | Chicago, IL | 42 | $210K |
| 7 | Paul Atkinson | Neurology | Roseville, MN | 38 | $195K |
| 8 | Kristen Batson | Nurse Practitioner | Orlando, FL | 15 | $184K |
| 9 | Nicholas Zendler | Neurology | Garden City, MI | 40 | $174K |
| 10 | Christine Baca | Neurology | Aurora, CO | 24 | $166K |
| 11 | Jennifer Vickers | Neurology | Albuquerque, NM | 110 | $158K |
| 12 | Toufic Fakhoury | Neurology | Lexington, KY | 87 | $157K |
| 13 | Ignacio Pita Garcia | Neurology | Guaynabo, PR | 37 | $144K |
| 14 | Ruth Dekker | Nurse Practitioner | Pocatello, ID | 35 | $143K |
| 15 | Maryam Mosharraf | Nurse Practitioner | Lexington, KY | 26 | $134K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
| 443 | Encorafenib (Braftovi) | $17.6M | 1,209 |
| 444 | Cladribine (Mavenclad) | $17.5M | 228 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology